Bliss Family Fund to Advance Cellular Therapies for WM supports investigators conducting trials of novel cellular immunotherapies and immune-redirection strategies to improve WM remissions and disease control.
The application deadline was extended from November 9, 2026, to January 26, 2027.
Grant Applications - CLL Global Research Foundation supports researchers studying CLL immunity, disease progression, and new treatments to accelerate advances in clinical care and the control and cure of CLL.
MPN Challenge™ supports researchers pursuing high-risk, high-reward studies of myeloproliferative neoplasms to deepen disease understanding, advance treatments, and improve patient care.
BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple Myeloma supports healthcare professionals through education on safe, effective bispecific antibody use to strengthen clinical practice.
General Research Funding from the CMT Research Foundation supports researchers and clinicians pursuing translational and discovery research to advance treatments for all types of Charcot-Marie-Tooth disease.
Cure IBM Research Fund at TMA supports researchers studying early muscle-fiber changes and disease mechanisms to advance understanding of inclusion body myositis causes, inflammation, and degeneration.